Find Federal Grants
Centers for Disease Control - CSELS · CDC-RFA-OE22-2203
Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AG-23-033
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
National Institutes of Health · PAS-22-197
Rural Utilities Service · RDRUS-22-01-DWS
Revolving Fund Program
Rural Utilities Service · RDRUS-22-RFP
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
National Institutes of Health · PAS-22-196
Pragmatic Clinical Trials in Community Settings to Decrease or Prevent VCID Outcomes, Including in Populations that Experience Health Disparities (U01 Clinical Trial Required)
National Institutes of Health · RFA-NS-23-001
Service Area Competition
Health Resources and Services Administration · HRSA-23-020
Registry of Medical Cannabis Use and Health Outcomes (UM1 - Clinical Trial Optional)
National Institutes of Health · RFA-DA-23-011
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional)
National Institutes of Health · PAR-22-199
Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional)
National Institutes of Health · PAR-22-198
Limited Competition: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-CA-22-026
Network for Personalization of Diagnostic Tests for Alzheimers Disease (AD) and Alzheimers Disease-Related Dementias (ADRD) in Older Adults with Multiple Chronic Conditions (MCCs) (U24 Clinical Trial Optional)
National Institutes of Health · RFA-AG-23-032
Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-DA-23-052
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)
National Institutes of Health · PAR-22-165
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)
National Institutes of Health · PAR-22-164
Rural Communities Opioid Response Program – Medication Assisted Treatment Access
Health Resources and Services Administration · HRSA-22-165
Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
National Institutes of Health · RFA-DA-23-019
India USAID-New Delhi · 72038622RFA00001
Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
National Institutes of Health · RFA-DA-23-020